- $33.72m
- -$7.85m
- $8.98m
InspireMD Inc expected to post a loss of 84 cents a share - Earnings Preview
InspireMD Inc expected to post a loss of 84 cents a share - Earnings Preview
InspireMD Inc reports results for the quarter ended in September - Earnings Summary
Brief: Inspiremd Reports Third Quarter Financial Results
InspireMD Inc expected to post a loss of 73 cents a share - Earnings Preview
Brief: InspireMD To Report Third Quarter 2022 Financial Results On November 8, 2022, And Provide Corporate Business Update
InspireMD Inc reports results for the quarter ended in June - Earnings Summary
Brief: InspireMD Reports Second Quarter 2022 Financial Results
Brief: InspireMD Inc Files For Mixed Shelf Of Up To $150 Million
InspireMD Inc reports results for the quarter ended in March - Earnings Summary
Brief: Inspiremd Reports First Quarter 2022 Financial Results And Business Update
InspireMD Inc expected to post a loss of 80 cents a share - Earnings Preview
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 04:23 PM
InspireMD Inc reports results for the quarter ended in December - Earnings Summary
Brief: InspireMD Reports Fourth Quarter And Year-End 2021 Financial Results
InspireMD Inc expected to post a loss of 78 cents a share - Earnings Preview
Brief: InspireMD Announces Inclusion Of Its CGuard Carotid Stent In Crest-2 Trial
InspireMD Inc reports results for the quarter ended in September - Earnings Summary